Ohio Plaintiffs In Xarelto Lawsuit Seek Compensation As FDA Issues Black Box Warnings

TheProductLawyers.com reports on an Ohio couple who have filed a lawsuit against the makers of Xarelto, a blood-thinning drug designed to treat patients afflicted with atrial fibrillation, pulmonary embolism, and deep vein thrombosis (DVT), as well as for those who have undergone hip and knee surgery. The couple's suit alleges that the manufacturers, Janssen Pharmaceuticals, a division of the Johnson and Johnson Corporation, and Bayer AG, failed to properly inform the public and medical professionals about the risks involved with taking Xarelto.

In the Ohio couple's court paperwork, they state that the wife was given Xarelto to treat her atrial fibrillation and, as a result, had suffered a gastrointestinal bleed and anemia only two months after beginning her treatment. The couple claims Xarelto caused the internal bleeding and they are seeking over $150,000 in compensatory damages to cover both current and future medical bills since she is now additionally being treated for other long-term medical conditions related to the bleeding.

Xarelto was approved for release on the market by the U.S. Food and Drug Administration (FDA) in 2011. However, since then the agency has issued Xarelto two black box warnings. A black box warning is a very harsh and severe one, and usually, portends the possible removal of a product from the consumer market.

In addition to the Ohio couple, there have been numerous other lawsuits filed in excess of 3,400 from all across America. In most, if not all of the cases, the plaintiffs uniformly allege that the anticoagulant has placed and will continue to place patients at a much higher risk for instances of dangerous, and sometimes fatal bleeding.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.